Cleared Special

K200680 - Synvitro Hyadase

K200680 is the FDA 510(k) clearance for Synvitro Hyadase by Origio A/S, A Coopersurgical Company. It is a Class 2 Obstetrics & Gynecology device (product code MQL) cleared through the Special 510(k) pathway after a 123-day FDA review.

K200680 · Origio A/S, A Coopersurgical Company · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2020
Decision
123d
Days
Class 2
Risk

K200680 is an FDA 510(k) clearance for the Synvitro Hyadase. Classified as Media, Reproductive (product code MQL), Class II - Special Controls.

Submitted by Origio A/S, A Coopersurgical Company (Måløv, DK). The FDA issued a Cleared decision on July 17, 2020 after a review of 123 days - within the typical 510(k) review window.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.6180 - the FDA obstetrics and gynecology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Origio A/S, A Coopersurgical Company devices

Submission Details

510(k) Number K200680 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 16, 2020
Decision Date July 17, 2020
Days to Decision 123 days
Submission Type Special
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
37d faster than avg
Panel avg: 160d · This submission: 123d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code MQL Media, Reproductive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.6180
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - MQL Media, Reproductive

All 121
Devices cleared under the same product code (MQL) and FDA review panel - the closest regulatory comparables to K200680.
VitaVitro® Fertilization Medium, VitaVitro® Gamete Buffer Medium, VitaVitro® Flushing Buffer Medium
K200408 · Shenzhen Vitavitro Biotech Co., Ltd. · Oct 2020
iMedium Single Step
K193522 · Kitazato Corporation · Aug 2020
Sperm Freeze, Sperm Fridge
K192845 · Kitazato Corporation · Aug 2020
GM501 SpermAir and GM501 SpermActive
K192644 · Hamilton Thorne Incorporated · Apr 2020
SepaSperm Washing Solution, SepaSperm Solution
K190199 · Kitazato Corporation · Sep 2019
GM501 Mineral Oil
K191552 · Hamilton Thorne, Inc. · Sep 2019